Point-of-Care Testing Found as Accurate as Laboratory Testing for Hepatitis B DNA

A clinical trial conducted by the Kirby Institute at UNSW Sydney has determined that point-of-care testing for hepatitis B DNA matches the accuracy of conventional laboratory testing. The findings, published in the Journal of Clinical Microbiology, suggest that this method could facilitate quicker diagnosis and treatment, particularly in remote or underserved communities.

The study evaluated the effectiveness of point-of-care testing compared to standard laboratory procedures. Researchers found no significant difference in accuracy between the two methods, indicating that portable diagnostic tools can reliably detect hepatitis B DNA. This development may address barriers to healthcare access by enabling immediate results and reducing reliance on centralized laboratories. The research highlights potential benefits for improving healthcare delivery in areas where traditional lab infrastructure is limited or inaccessible.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 8, 2026

Author

GOAI